David Hollander

David Hollander

Director/Board Member at KIORA PHARMACEUTICALS, INC.

Net worth: - $ as of 30/05/2026

52 year
Health Technology
Consumer Services
Miscellaneous

Profile

David A. Hollander is an Independent Director at Kiora Pharmaceuticals, Inc. since 2021 and a Director at Arnold & Mabel Beckman Foundation.
Former roles include VP & Head-Eye Care for Global Medical Affairs at Allergan, Inc., Chief Research & Development Officer at Aerie Pharmaceuticals, Inc. from 2019 to 2022, Chief Medical Officer & Senior Vice President at Ora, Inc., and Chief Medical Officer at Revance Therapeutics, Inc. from 2022 to 2025.
Education includes undergraduate studies at Stanford University, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
09/06/2026 0 ( -.--% ) - $ 30/05/2026

David Hollander active positions

CompaniesPositionStart
KIORA PHARMACEUTICALS, INC. Director/Board Member 12/12/2021
Director/Board Member -

Former positions of David Hollander

CompaniesPositionEnd
REVANCE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 03/02/2025
AERIE PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 27/02/2022
ALLERGAN, INC. Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
See the detail of David Hollander's experience

Training of David Hollander

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Miscellaneous

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. David Hollander
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!